Gabapentin decreases monoamine release without affecting acetylcholine release in the brain

Area of Science:

• Neuroscience
• Pharmacology

Background:

• Gabapentin is an amino acid structurally related to gamma-aminobutyric acid (GABA).
• Its precise mechanism of action, particularly concerning neurotransmitter release, remains incompletely understood.

Purpose of the Study:

• To investigate the effects of gabapentin on the electrically evoked release of 3H-noradrenaline and 3H-serotonin from rat brain cortex slices.
• To determine if gabapentin's effects are mediated through GABA receptors or other known neurotransmitter pathways.

Main Methods:

• Superfusion of rat brain cortex slices preincubated with 3H-noradrenaline or 3H-serotonin.
• Superfusion of rabbit caudate nucleus slices preincubated with 3H-choline.
• Electrical stimulation to evoke neurotransmitter overflow.
• Concentration-dependent assessment of gabapentin's effects.
• Testing the influence of various receptor antagonists and reuptake inhibitors.

Main Results:

• Gabapentin demonstrated a concentration-dependent inhibition of electrically evoked 3H overflow from slices preincubated with 3H-monoamines (noradrenaline, serotonin).
• Gabapentin did not affect the evoked overflow of 3H-choline from rabbit caudate nucleus slices.
• The inhibitory effects of gabapentin were not modified by bicuculline, RS-baclofen, GABA, phentolamine, metitepin, cocaine, or 6-nitroquipazine.
• Gabapentin did not alter the inhibitory effect of GABA on 3H-serotonin overflow.

Conclusions:

• Gabapentin exhibits inhibitory effects on noradrenaline and serotonin release, mimicking GABAB receptor activation.
• However, these effects appear to be mediated through a GABA receptor-independent mechanism.
• The study suggests an as-yet unidentified mechanism underlying gabapentin's action on neurotransmitter release.